EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application

Ling Yin, Hongliang He iD, Hongliang Zhang, Yuhua Shang, Chengbo Fu, Songquan Wu, Tengchuan Jin iD

Journal of Medical Virology · 2025-06 · 97 (6)

DOI: 10.1002/jmv.70447 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 19.06.2025. Verfasst von Ling Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Disease Immunity and Intervention, College of Medicine, Lishui University, Lishui, China. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Genetic Therapy, Drug Discovery. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 321 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: T.J. is supported by the National Key Research and Development Program of China (Grants No. 2022YFC2304102 and 2022YFC2303300), the Strategic Priority Research….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adeno‐associated virus (AAV) is a non‐enveloped DNA virus infecting a wide variety of species, tissues, and cell types, which is recognized as a safe and effective method for delivering therapeutic transgenes. AAV vector is the most popular viral gene delivery system in clinical delivery systems with unique and multiple advantages, such as tissue tropism, transduction specificity, long‐lasting gene expression, low immune responses, and without host chromosome incorporation. Till now, four AAV‐based gene therapy drugs have already been approved by the US Food and Drug Administration (FDA) or European Medicines Agency (EMA). Despite the success of AAV vectors, there are still some remaining challenges that limit further usage, such as poor packaging capacity, low organ specificity, pre‐existing humoral immunity, and vector dose‐dependent toxicity. In the present review, we address the different approaches to optimize AAV vector delivery system with a focus on capsid engineering, packaging capacity, and immune response at the clinical level. The review further investigates the potential of manipulating AAV vectors in preclinical applications and clinical translation, which emphasizes the challenges and prospects in viral vector selection, drug delivery strategies, immune reactions in cancer, neurodegenerative disease, retinal disease, SARS‐CoV‐2, and monkeypox. Finally, it forecasts future directions and potential challenges of artificial intelligence (AI), vaccines, and nanobodies, which emphasizes the need for ethical and secure approaches in AAV application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsGenetic TherapyDrug DiscoveryGene Transfer TechniquesDrug Delivery SystemsHumansAnimalsCOVID-19SARS-CoV-2

Stichwörter der Autor:innen

AAVclinical applicationdelivery systemdrug discovery

Autor:innen und Institutionen

  • Center of Disease Immunity and Intervention, College of Medicine, Lishui University, Lishui, China.
  • College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, Anhui, China.
  • Biomedical Sciences and Health Laboratory of Anhui Province, University of Science & Technology of China, Hefei, Anhui, China.
  • Laboratory of Structural Immunology, National Key Laboratory of Immune Response and Immunotherapy, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

ORCID-Profile: Hongliang He, Tengchuan Jin

Förderung

  • T.J. is supported by the National Key Research and Development Program of China (Grants No. 2022YFC2304102 and 2022YFC2303300), the Strategic Priority Research…

Zitieren

APA

Yin, L., He, H., Zhang, H., Shang, Y., Fu, C., Wu, S., & Jin, T. (2025). Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application. Journal of Medical Virology, 97(6). https://doi.org/10.1002/jmv.70447

Vancouver

Yin L, He H, Zhang H, Shang Y, Fu C, Wu S, et al. Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application. Journal of Medical Virology. 2025;97(6). doi:10.1002/jmv.70447

BibTeX
@article{Yin2025,
  author = {Yin, Ling and He, Hongliang and Zhang, Hongliang and Shang, Yuhua and Fu, Chengbo and Wu, Songquan and Jin, Tengchuan},
  title = {Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {6},
  doi = {10.1002/jmv.70447}
}
Kostenlos starten →